<bill session="116" type="h" number="6155" updated="2020-09-28T14:30:09Z">
  <state datetime="2020-03-09">REFERRED</state>
  <status>
    <introduced datetime="2020-03-09"/>
  </status>
  <introduced datetime="2020-03-09"/>
  <titles>
    <title type="official" as="introduced">To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition of biological products, and for other purposes.</title>
    <title type="display">To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition of biological products, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="G000576"/>
  <cosponsors/>
  <actions>
    <action datetime="2020-03-09">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-03-09" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="116" relation="unknown" number="2103"/>
    <bill type="s" session="116" relation="unknown" number="1895"/>
    <bill type="h" session="116" relation="unknown" number="19"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Licensing and registrations"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
